Study S000568

An Observational Study of Glycemic Control and Cardiovascular Outcomes Among Patients With Type 2 Diabetes Newly Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP1) Versus Basal Insulin in Routine Care Settings

ClinicalTrials.gov record

Registration

Registration: NCT04034524
Study type: OBSERVATIONAL
Status: UNKNOWN
Enrollment: 20000
Start: 2019-05-01
Primary completion: 2020-12-31
Lead sponsor: Brigham and Women's Hospital
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:GLP-1 receptor agonist; DRUG:Insulin
Results posted: FALSE

Registered primary outcomes

Time until first composite CV event (myocardial infarction, stroke) [Through Study Completion, an estimated average of 1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.